The OAC is excited to have Currax Pharmaceuticals join the OAC Chairman’s Council at the Silver level. Currax Pharmaceuticals is a specialty biopharmaceutical company focused on enhancing the lives of patients by expanding access to life-changing medications that treat diseases such as obesity. The Currax portfolio includes CONTRAVE® (naltrexone HCl/bupropion HCl), the number one
Read Article